Funding

www.brcophthalmology.org/Default.aspx
The NIHR Moorfields Biomedical Research Centre (BRC) is dedicated to vision research. After a five-year term starting in 2007, we received a new NIHR (National Institute for Health Research) award in 2012 for another five years to support our strategy founded on six methodological research themes for research into the major common vision problems (age-related macular degeneration, diabetic retinopathy and glaucoma) as well as rare eye diseases. We continue to prioritise areas where there is unmet patient need and where we have an outstanding track record of translational achievement and expertise at an international level. We have built infrastructure around these themes, growing strategic partnerships and collaborations and building capacity to support and consolidate all the links of the translational bridge. As a result, new treatment techniques and practices that improve patient health are being brought through to clinical and surgical practice as quickly as possible, thereby benefiting patients, as well as the NHS, universities and the UK as a whole.

www.moorfields.nhs.uk/content/moorfields-eye-charity-1
Moorfields Eye Charity (Formerly, The Special Trustees of Moorfields Eye Hospital) is a grant-giving body, and its objects are any charitable purpose relating wholly or mainly for Moorfields Eye Hospital. In order to achieve their objectives the Trustees work closely with Moorfields and its research partners, principally the UCL Institute of Ophthalmology, to support their research and capital expenditure plans. (Charity number 1140679)

www.fightforsight.org.uk
Fight for Sight has been funding research into blindness and eye disease for more than 40 years. There has been major progress in this time but there is still much more to do.

www.nerc-charity.org.uk
NERC is a UK charity which raises money to fund research into the causes of eye disease, the development of treatments and the prevention of blindness.

www.glaucoma-association.com
This website is a comprehensive source of up-to-date news and information about glaucoma, and is provided as a free service by the International Glaucoma Association (IGA). The IGA is a patient-based organisation which works to prevent glaucoma blindness by providing information, literature and advice.

www.myalcon.com/research-development/alcon-research-institute/index.shtml
Alcon supports serious research in eye health and works to expand the frontiers of ophthalmic and optometric sciences through the Alcon Research Institute (ARI).

www.bhf.org.uk
British Heart Foundation are the UK's number one heart charity and through 50 years of funding cutting edge research. Today. they are funding thousands of research projects around the UK that are fighting heart disease. Two groups within our consortium are actively developing new methods of examining the characteristics of retinal blood vessels to assess risk of disease. One group are based at St George’s, University of London (Dr Christopher Owen, Dr Alicja Rudnicka, Professor Peter Whincup, Professor David Strachan) and Kingston University (Dr Sarah Barman), funded by the British Heart Foundation.

www.macularsociety.org/
The Macular Society is the national charity for anyone affected by central vision loss. With over 21,000 members The Macular Society are the biggest membership group in the sight loss sector and the voice of people with macular conditions. The Macular Society provide free information and support to improve lives and ensure no one has to face macular disease alone. There are around 300 Macular Society support groups around the UK and beyond. The Macular Society fund research so that one day we can overcome macular disease.

www.wellcome.ac.uk
The Wellcome Trust is an independent global charitable foundation dedicated to improving health.

www.mrc.ac.uk
The Medical Research Council improves human health through world-class medical research. They fund research across the biomedical spectrum, from fundamental lab-based science to clinical trials, and in all major disease areas.